CHICAGO, Oct. 31, 2022 /PRNewswire/ -- ELISpot and FluoroSpot Assay Market size is projected to reach USD 390 million by 2027 from USD 274 million in 2022, at a CAGR of 7.3% during the forecast period according to a new report by MarketsandMarkets. Market is driven by factors such as global prevalence of chronic and infectious diseases and the growing awareness for early disease diagnosis, the rising use of ELISpot assays as diagnostic tool in drug hypersensitivity reaction. On the other hand, a unpermissive requirements for approval of ELISpot and FluoroSpot assay instruments and consumables is expected to limit market growth to a certain extent in the coming years. Upsurge in the cases of cancer amongst global population is anticipated to drive the ELISpot and FluoroSpot Assays Market growth. Use of FluoroSpot assays for multiple-analyte detection in single well is anticipated to propel market growth opportunities. However, availability of lack of skilled professionals is anticipated to hinder market development.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124350584
Browse in-depth TOC on "ELISpot and FluoroSpot Assay Market"
134 - Tables
47 - Figures
192 - Pages
EliSpot Assay kits in the kits product segment to witness the highest shares during the forecast period."
Based on the product, Based on the product, the ELISpot and FluoroSpot Assays Market is classified into Assay Kits (By Technique - ELISpot Assay Kits, FluoroSpot Assay Kits., By Utility - Research Kits, Diagnostic Kits., By Analyte - T-cell-based Kits, B-cell-based Kits, Other Analyte Kits), Analyzers, Ancillary Products. The EliSpot Assay kits,segment is expected to dominate because of its wider application as these are widely used for research as well as diagnostic applications and the advantages in terms of high specificity and sensitivity and better detection limits as compared to other assays such as ELISA. likewise, several players are focusing on introducing new products in the market to strengthen their product offerings. These are the key factors driving the growth of the EliSpot kits in the market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=124350584
US dominates the North American ELISpot and FluoroSpot Assays Market
Based on the North America region, the ELISpot and FluoroSpot Assays Market is divided into US and Canada. US is expected to dominate the ELISpot and FluoroSpot Assays Market. rising prevalence of chronic diseases, increasing focus on vaccine development, rapidly increasing geriatric population, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers., are the key factor driving market growth in the US.
The major players in the ELISpot and FluoroSpot Assays Market are Oxford Immunotec (UK), Cellular Technology Limited (US), Mabtech (Sweden), Becton, Dickinson and Company (US), Abcam plc. (UK), Bio-Techne.(US), Mikrogen Diagnostik (Germany), Autoimmun Diagnostika GmbH (Germany), U-CyTech (Netherland), and Medix Biochemica (Finland)
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=124350584
Browse Adjacent Market: Medical Devices Market Research Reports & Consulting
Related Reports:
Immunoassay Market - Global Forecasts to 2027
Infectious Disease Diagnostics Market - Global Forecasts to 2027
In Vitro Diagnostics Market - Global Forecasts to 2026
Lateral Flow Assays Market - Global Forecasts to 2026
Multiplex Assays Market - Global Forecasts to 2026
About MarketsandMarkets
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/elispot-fluorospot-assay-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/elispot-fluorospot-assay.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/elispot-and-fluorospot-assay-market-worth-390-million-by-2027---exclusive-report-by-marketsandmarkets-301663122.html
